Scinai Immunotherapeutics Dividend
Dividend criteria checks 0/6
Scinai Immunotherapeutics does not have a record of paying a dividend.
Key information
n/a
Dividend yield
n/a
Payout ratio
Industry average yield | 2.9% |
Next dividend pay date | n/a |
Ex dividend date | n/a |
Dividend per share | n/a |
Earnings per share | -US$2.13 |
Dividend yield forecast in 3Y | n/a |
Recent dividend updates
No updates
Recent updates
Here's Why BiondVax Pharmaceuticals (NASDAQ:BVXV) Can Afford Some Debt
Nov 10Bionvax Pharmaceuticals GAAP EPS of -NIS0.02
Aug 25BiondVax, European Investment Bank agree on new terms to co's outstanding €24M loan
Aug 10We Think BiondVax Pharmaceuticals (NASDAQ:BVXV) Has A Fair Chunk Of Debt
Mar 31BiondVax Pharmaceuticals under pressure on pricing $12.1M ADSs follow-on offering
Jan 29Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if SCNI's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if SCNI's dividend payments have been increasing.
Dividend Yield vs Market
Scinai Immunotherapeutics Dividend Yield vs Market |
---|
Segment | Dividend Yield |
---|---|
Company (SCNI) | n/a |
Market Bottom 25% (US) | 1.6% |
Market Top 25% (US) | 4.8% |
Industry Average (Biotechs) | 2.9% |
Analyst forecast in 3 Years (SCNI) | n/a |
Notable Dividend: Unable to evaluate SCNI's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate SCNI's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate SCNI's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as SCNI has not reported any payouts.